S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How Biden has already won 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How Biden has already won 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How Biden has already won 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How Biden has already won 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

BioMarin Pharmaceutical (BMRN) Insider Trading & Ownership

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free bmrn Stock Alerts
$88.63
-1.44 (-1.60%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.84%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$18.01 M
Get BMRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BMRN Insider Buying and Selling by Quarter

Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

BioMarin Pharmaceutical Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.00  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.68  
3/5/2024Henry J FuchsInsiderSell35,341$85.18$3,010,346.38  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.00  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.20  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.00  
8/10/2023Henry J FuchsInsiderSell12,000$90.43$1,085,160.00  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.00  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00  
(Data available from 1/1/2013 forward)

BMRN Insider Trading Activity - Frequently Asked Questions

Who is on BioMarin Pharmaceutical's Insider Roster?

The list of insiders at BioMarin Pharmaceutical includes Brian Mueller, Charles Greg Guyer, Dennis Slamon, Erin Burkhart, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Mark J Alles, Richard A Meier, and V Bryan Lawlis. Learn more on insiders at BMRN.

What percentage of BioMarin Pharmaceutical stock is owned by insiders?

1.84% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings.

Which BioMarin Pharmaceutical insiders have been buying company stock?

The following insider purchased BMRN shares in the last 24 months: Mark J Alles ($314,468.75).

How much insider buying is happening at BioMarin Pharmaceutical?

Insiders have purchased a total of 3,625 BMRN shares in the last 24 months for a total of $314,468.75 bought.

Which BioMarin Pharmaceutical insiders have been selling company stock?

The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($3,471,434.67), Charles Greg Guyer ($599,154.80), Erin Burkhart ($205,740.00), George Eric Davis ($6,368,081.74), Henry J Fuchs ($4,095,506.38), Jean Jacques Bienaime ($20,988,285.00), Jeffrey Robert Ajer ($7,116,053.52), Richard A Meier ($318,345.02), and V Bryan Lawlis ($825,265.00).

How much insider selling is happening at BioMarin Pharmaceutical?

Insiders have sold a total of 462,146 BioMarin Pharmaceutical shares in the last 24 months for a total of $43,987,866.13 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BMRN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends